Cantor Fitzgerald, L. P. Lucid Diagnostics Inc. Transaction History

Cantor Fitzgerald, L. P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.53 - $3.45 $105,667 - $238,270	-69,064 Reduced 20.7%	264,653 $405,000
Q1 2022 May 16, 2022	SELL	$2.85 - $5.24 $237,775 - $437,173	-83,430 Reduced 20.0%	333,717 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$4.87 - $11.76 $2.03 Million - $4.91 Million	417,147 New	417,147 $2.24 Million

2.54M

Ticker LUCD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 38,568,500
Market Cap $38.6M
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.